Search research articles
Contact Us
Filters
Showing results (291-300 of 460) with videos related to
Page
of 46
Sort By:
Science Translational Medicine
|
December 3, 2020
A blueprint for translational regenerative medicine
James P K Armstrong, Timothy J Keane, Anne C Roques, et al.
Neurobiology of Aging
|
January 21, 2014
Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals
Ricardo S Osorio, Indu Ayappa, Janna Mantua, et al.
Biomolecules
|
March 1, 2019
Structural and Dynamical Order of a Disordered Protein: Molecular Insights into Conformational Switching of PAGE4 at the Systems Level
Xingcheng Lin, Prakash Kulkarni, Federico Bocci, et al.
Science Translational Medicine
|
April 29, 2011
Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells
Marcus O Butler, Philip Friedlander, Matthew I Milstein, et al.
JCO Precision Oncology
|
September 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)
Margaret E Macy, Rajen Mody, Joel M Reid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2022
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial
Olive S Eckstein, Carl E Allen, P Mickey Williams, et al.
JCO Precision Oncology
|
June 27, 2024
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial
Kieuhoa T Vo, Amit J Sabnis, P Mickey Williams, et al.
JCO Precision Oncology
|
September 19, 2024
Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D
Theodore W Laetsch, Kathleen Ludwig, P Mickey Williams, et al.
The Oncologist
|
May 30, 2024
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial
Julia L Glade Bender, Kerice Pinkney, Paul M Williams, et al.
The Oncologist
|
June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G
Marie V Nelson, AeRang Kim, P Mickey Williams, et al.
Page
of 46
Search research articles
Search
Showing results (291-300 of 460) with videos related to
Sort By:
Page
of 46
Science Translational Medicine
|
December 3, 2020
A blueprint for translational regenerative medicine
James P K Armstrong, Timothy J Keane, Anne C Roques, et al.
Neurobiology of Aging
|
January 21, 2014
Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals
Ricardo S Osorio, Indu Ayappa, Janna Mantua, et al.
Biomolecules
|
March 1, 2019
Structural and Dynamical Order of a Disordered Protein: Molecular Insights into Conformational Switching of PAGE4 at the Systems Level
Xingcheng Lin, Prakash Kulkarni, Federico Bocci, et al.
Science Translational Medicine
|
April 29, 2011
Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells
Marcus O Butler, Philip Friedlander, Matthew I Milstein, et al.
JCO Precision Oncology
|
September 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)
Margaret E Macy, Rajen Mody, Joel M Reid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2022
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial
Olive S Eckstein, Carl E Allen, P Mickey Williams, et al.
JCO Precision Oncology
|
June 27, 2024
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial
Kieuhoa T Vo, Amit J Sabnis, P Mickey Williams, et al.
JCO Precision Oncology
|
September 19, 2024
Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D
Theodore W Laetsch, Kathleen Ludwig, P Mickey Williams, et al.
The Oncologist
|
May 30, 2024
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial
Julia L Glade Bender, Kerice Pinkney, Paul M Williams, et al.
The Oncologist
|
June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G
Marie V Nelson, AeRang Kim, P Mickey Williams, et al.
Page
of 46